In vivo assessment of dopaminergic variables in schizophrenia.
SHFJ-CEA, Orsay, France.
J L
JL
Martinot
M L
ML
Paillere-Martinot
Y
Y
Lecrubier
M H
MH
Dao-Castellana
C
C
Loc'h
M F
MF
Poirier
J F
JF
Allilaire
A
A
Feline
A
A
Manus
F
F
Aubin
D004298:Dopamine / Q000502:physiology*; D015259:Dopamine Agents / Q000627:therapeutic use; D006801:Humans; D011954:Receptors, Dopamine / Q000187:drug effects / Q000378:metabolism*; D017448:Receptors, Dopamine D2; D012559:Schizophrenia / Q000188:drug therapy / Q000378:metabolism*; D014055:Tomography, Emission-Computed
D015259:Dopamine Agents; D011954:Receptors, Dopamine; D017448:Receptors, Dopamine D2; D004298:Dopamine